Literature DB >> 30593885

Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V.

Jean-Marc Retrouvey1, Doaa Taqi2, Faleh Tamimi2, Didem Dagdeviren2, Francis H Glorieux3, Brendan Lee4, Renna Hazboun5, Deborah Krakow6, V Reid Sutton4.   

Abstract

Osteogenesis imperfecta (OI) type V is an ultrarare heritable bone disorder caused by the heterozygous c.-14C > T mutation in IFITM5. The oro-dental and craniofacial phenotype has not been described in detail, which we therefore undertook to evaluate in a multicenter study (Brittle Bone Disease Consortium). Fourteen individuals with OI type V (age 3-50 years; 10 females, 4 males) underwent dental and craniofacial assessment. None of the individuals had dentinogenesis imperfecta. Six of the 9 study participants (66%) for whom panoramic radiographs were obtained had at least one missing tooth (range 1-9). Class II molar occlusion was present in 8 (57%) of the 14 study participants. The facial profile was retrusive and lower face height was decreased in 8 (57%) individuals. Cephalometry, performed in three study participants, revealed a severely retrusive maxilla and mandible, and moderately to severly retroclined incisors in a 14-year old girl, a protrusive maxilla and a retrusive mandible in a 14-year old boy. Cone beam computed tomograpy scans were obtained from two study participants and demonstrated intervertebral disc calcification at the C2-C3 level in one individual. Our study observed that OI type V is associated with missing permanent teeth, especially permanent premolar, but not with dentinogenesis imperfecta. The pattern of craniofacial abnormalities in OI type V thus differs from that in other severe OI types, such as OI type III and IV, and could be described as a bimaxillary retrusive malocclusion with reduced lower face height and multiple missing teeth.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Craniofacial; Dental; Fractures; IFITM5; Oligodontia; Osteogenesis imperfecta

Mesh:

Year:  2018        PMID: 30593885      PMCID: PMC6594916          DOI: 10.1016/j.ejmg.2018.12.011

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  36 in total

1.  Brachycephalic, dolichocephalic and mesocephalic: Is it appropriate to describe the face using skull patterns?

Authors:  Fernanda Catharino Menezes Franco; Telma Martins de Araujo; Carlos Jorge Vogel; Cátia Cardoso Abdo Quintão
Journal:  Dental Press J Orthod       Date:  2013 May-Jun

2.  Osteogenesis imperfecta type V: clinical and radiographic manifestations in mutation confirmed patients.

Authors:  Ok-Hwa Kim; Dong-Kyu Jin; Keisuke Kosaki; Jung-Wook Kim; Sung Yoon Cho; Won Joon Yoo; In Ho Choi; Gen Nishimura; Shiro Ikegawa; Tae-Joon Cho
Journal:  Am J Med Genet A       Date:  2013-06-26       Impact factor: 2.802

3.  A soft-tissue cephalometric analysis and its use in orthodontic treatment planning. Part I.

Authors:  R A Holdaway
Journal:  Am J Orthod       Date:  1983-07

4.  The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

Authors:  Leonid Zeitlin; Frank Rauch; Rose Travers; Craig Munns; Francis H Glorieux
Journal:  Bone       Date:  2005-09-12       Impact factor: 4.398

5.  Evaluation of the severity of malocclusions in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy indexes.

Authors:  Jean Rizkallah; Stephane Schwartz; Frank Rauch; Francis Glorieux; Duy-Dat Vu; Katia Muller; Jean-Marc Retrouvey
Journal:  Am J Orthod Dentofacial Orthop       Date:  2013-03       Impact factor: 2.650

6.  The natural history of cervical disc calcification in children.

Authors:  Li-Yang Dai; Hua Ye; Qi-Rong Qian
Journal:  J Bone Joint Surg Am       Date:  2004-07       Impact factor: 5.284

7.  Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients.

Authors:  Frank Rauch; Pierre Moffatt; Moira Cheung; Peter Roughley; Liljana Lalic; Allan M Lund; Norman Ramirez; Somayyeh Fahiminiya; Jacek Majewski; Francis H Glorieux
Journal:  J Med Genet       Date:  2013-01       Impact factor: 6.318

8.  Oral findings in osteogenesis imperfecta.

Authors:  S Schwartz; P Tsipouras
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-02

9.  Tooth agenesis in osteogenesis imperfecta related to mutations in the collagen type I genes.

Authors:  B Malmgren; K Andersson; K Lindahl; A Kindmark; G Grigelioniene; V Zachariadis; G Dahllöf; E Åström
Journal:  Oral Dis       Date:  2016-09-13       Impact factor: 3.511

10.  A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.

Authors:  Oliver Semler; Lutz Garbes; Katharina Keupp; Daniel Swan; Katharina Zimmermann; Jutta Becker; Sandra Iden; Brunhilde Wirth; Peer Eysel; Friederike Koerber; Eckhard Schoenau; Stefan K Bohlander; Bernd Wollnik; Christian Netzer
Journal:  Am J Hum Genet       Date:  2012-08-02       Impact factor: 11.043

View more
  4 in total

Review 1.  Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

Authors:  Milena Jovanovic; Gali Guterman-Ram; Joan C Marini
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

2.  Osteogenesis imperfecta tooth level phenotype analysis: Cross-sectional study.

Authors:  Doaa Taqi; Hanan Moussa; Timothy Schwinghamer; Maxime Ducret; Didem Dagdeviren; Jean-Marc Retrouvey; Frank Rauch; Faleh Tamimi
Journal:  Bone       Date:  2021-03-16       Impact factor: 4.626

3.  Dental phenotype in an adolescent with osteogenesis imperfecta type XII.

Authors:  Joanna Yuet-Ling Tung; Jeni Lai-In Ho; Ricky Wong; Siu-Chung Fung
Journal:  BMJ Case Rep       Date:  2022-04-13

4.  Evaluation of the Severity of Malocclusion in Children with Osteogenesis Imperfecta.

Authors:  Manuel Joaquín De Nova-García; Fabiola Bernal-Barroso; Maria Rosa Mourelle-Martínez; Nuria Esther Gallardo-López; Montserrat Diéguez-Pérez; Gonzalo Feijoo-García; Laura Burgueño-Torres
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.